Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Will US Government Pursue Fewer False Claims Act Cases In 2019?

Executive Summary

Fallout from Supreme Court's Escobar decision and Department of Justice memos could impact types of healthcare fraud complaints in which the government intervenes.


Related Content

US False Claims Act Dismissal Motions Are Executive Branch Over-Reach, Whistleblowers Say
Opioid Makers May Have To Pay For Prevention Costs Of 'Man-Made Plague,' Judge Suggests
False Claims Act: US Justice Department Gives Pharma Early Christmas Present
US Enforcement 2019: Compounding, Opioids Top Priorities But Beware Of REMS Violations, Too
Actelion Is Third Company To Settle Charity Co-Pay Kickback Claims With DOJ
AmerisourceBergen Settlement On Injectable Drug Repackaging Includes Forfeiture Of Exec Pay
AbbVie Deployed Nurses As 'Runners And Cappers' In Humira Kickback Scheme, Suit Alleges
Government Pharma Investigations Target Pricing, Opioids, Trade Practices
Opioid Litigation: US DOJ Intensifies Pressure On Sponsors With New Task Force
Copay Kickback Enforcement Gains Momentum: United Therapeutics Settles Charges


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts